GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (WBO:MRCK) » Definitions » E10

Merck KGaA (WBO:MRCK) E10 : €5.85 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Merck KGaA E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Merck KGaA's adjusted earnings per share data for the three months ended in Dec. 2023 was €1.340. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €5.85 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Merck KGaA's average E10 Growth Rate was 9.30% per year. During the past 3 years, the average E10 Growth Rate was 16.80% per year. During the past 5 years, the average E10 Growth Rate was 14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Merck KGaA was 16.80% per year. The lowest was -1.30% per year. And the median was 14.10% per year.

As of today (2024-04-30), Merck KGaA's current stock price is €149.75. Merck KGaA's E10 for the quarter that ended in Dec. 2023 was €5.85. Merck KGaA's Shiller PE Ratio of today is 25.60.

During the past 13 years, the highest Shiller PE Ratio of Merck KGaA was 53.66. The lowest was 19.64. And the median was 30.54.


Merck KGaA E10 Historical Data

The historical data trend for Merck KGaA's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA E10 Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.43 3.68 4.44 5.43 5.85

Merck KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.43 5.66 5.74 5.87 5.85

Competitive Comparison of Merck KGaA's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Shiller PE Ratio falls into.



Merck KGaA E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck KGaA's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.34/123.6675*123.6675
=1.340

Current CPI (Dec. 2023) = 123.6675.

Merck KGaA Quarterly Data

per share eps CPI Adj_EPS
201403 0.750 99.543 0.932
201406 0.700 99.543 0.870
201409 0.570 99.823 0.706
201412 0.640 99.543 0.795
201503 0.650 99.717 0.806
201506 0.790 100.417 0.973
201509 0.840 100.417 1.034
201512 0.290 99.717 0.360
201603 1.360 100.017 1.682
201606 0.720 100.717 0.884
201609 1.050 101.017 1.285
201612 0.620 101.217 0.758
201703 1.200 101.417 1.463
201706 0.980 102.117 1.187
201709 1.480 102.717 1.782
201712 2.330 102.617 2.808
201803 0.780 102.917 0.937
201806 0.570 104.017 0.678
201809 0.780 104.718 0.921
201812 5.630 104.217 6.681
201903 0.430 104.217 0.510
201906 1.080 105.718 1.263
201909 0.790 106.018 0.922
201912 0.730 105.818 0.853
202003 1.050 105.718 1.228
202006 0.670 106.618 0.777
202009 1.850 105.818 2.162
202012 1.000 105.518 1.172
202103 1.720 107.518 1.978
202106 1.710 108.486 1.949
202109 1.750 109.435 1.978
202112 1.850 110.384 2.073
202203 2.020 113.968 2.192
202206 1.990 115.760 2.126
202209 2.120 118.818 2.207
202212 1.510 119.345 1.565
202303 1.830 122.402 1.849
202306 1.620 123.140 1.627
202309 1.700 124.195 1.693
202312 1.340 123.668 1.340

Add all the adjusted EPS together and divide 10 will get our e10.


Merck KGaA  (WBO:MRCK) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Merck KGaA's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=149.75/5.85
=25.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Merck KGaA was 53.66. The lowest was 19.64. And the median was 30.54.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Merck KGaA E10 Related Terms

Thank you for viewing the detailed overview of Merck KGaA's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA (WBO:MRCK) Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA (WBO:MRCK) Headlines

No Headlines